A LY3437943 certificate of analysis follows the same general layout as any lyophilized peptide COA, covered generally in how to read a peptide certificate of analysis. What is worth walking through separately is what each section actually needs to show for this specific molecule: a large, 39-residue, fatty-acid-conjugated peptide with a published molecular formula of C256H392N64O79 and a molecular weight of 4731.2. That size and structure change what a passing result on identity, purity and net peptide content should look like compared with a short, unmodified peptide.
| Test | What it should show for LY3437943 | Why it matters for this molecule |
|---|---|---|
| Mass spectrometry identity | Observed mass matching 4731.2 within the lab's stated tolerance | Confirms the lipidated backbone, not just a peptide of similar size |
| HPLC purity | A single dominant peak, reported at a stated wavelength | The fatty diacid chain shifts retention time versus an unmodified peptide, so the method must be validated for this molecule |
| Net peptide content | Percentage of powder mass that is actual peptide, separate from purity | Counter-ion and bound-water content can be proportionally larger on a heavier, more complex molecule |
| Endotoxin | Result below the lab's stated limit, usually by the LAL method | Relevant for any cell-based assay work with the reconstituted material |
Why does mass spectrometry identity matter more for a molecule this size?
LY3437943's reported molecular weight, 4731.2, sits well above the range of a short unmodified peptide, and its formula, C256H392N64O79, reflects both the 39-residue backbone and the attached fatty diacid chain. A mass spec identity test that only confirms "a peptide of roughly the right size" is not doing the same job as one that confirms the specific mass associated with the intact, lipidated molecule. A COA reporting purity without a corresponding identity result tells a lab the sample is clean, not what it is clean of, which matters more for a structurally complex, multi-domain molecule like this one than for a simple short peptide where synthesis errors are easier to rule out by other means.
Why can HPLC purity numbers be harder to compare across labs for a lipidated peptide?
LY3437943's fatty diacid chain makes the finished molecule more hydrophobic than an unmodified peptide, which shifts its retention behavior in reversed-phase HPLC, the standard method behind most purity numbers. Two labs running purity on the same lot but with different gradient conditions, column chemistry or detection wavelength can report numbers that are not directly comparable, even though both are technically valid HPLC purity results. This is not unique to LY3437943; it is a general property of any lipidated, fatty-acid-conjugated peptide, and it is one more reason a COA is only fully useful when it also states the method conditions rather than a bare percentage. General background on what an HPLC purity percentage does and does not tell you is covered in the site's dedicated purity guide, linked from the general COA article above.
What does net peptide content add beyond the purity number?
Lyophilized powder is never pure peptide by weight. It carries bound water and counter-ions, commonly trifluoroacetate residue left over from purification, and net peptide content is the test that quantifies what fraction of the total powder mass is actually peptide. For a larger, heavier molecule like LY3437943, the counter-ion contribution does not necessarily scale the same way it would for a short peptide, so treating the labeled vial mass as equivalent to peptide mass without checking net content can introduce more error on a bigger molecule, not less. A COA that reports HPLC purity in the high nineties but omits net peptide content has still left this question open. General background on the distinction between the two figures, and on why a 99 percent pure vial is not 99 percent peptide by weight, is covered in net peptide content vs purity, and the mechanics of what an HPLC purity percentage measures in the first place are covered in HPLC purity explained.
What does an endotoxin result on a LY3437943 COA actually test for?
Endotoxin testing looks for bacterial lipopolysaccharide contamination, a biological hazard that neither mass spectrometry nor HPLC purity testing is designed to detect. The limulus amebocyte lysate (LAL) method is the long-standing standard assay for this, reviewed in detail by Bolden and colleagues, who cover recovery and interference issues that can affect LAL results on a given sample matrix (Bolden et al., 2016). Fennrich and colleagues' review of pyrogen detection methods covers the broader landscape of endotoxin and pyrogen testing approaches, including alternatives to LAL that have been developed as the method has matured (Fennrich et al., 2016). For any planned cell-culture work, an endotoxin result, or its absence from the certificate, is one of the first things worth checking, a point covered in more general terms in beyond purity: endotoxin, sterility and heavy-metal testing.
What should a lab do if a LY3437943 COA is missing one of these sections?
A COA with purity but no identity result has confirmed cleanliness without confirming content. A COA with identity and purity but no net peptide content has left open how much of the vial's labeled mass is actually peptide. A COA with no endotoxin result is a meaningful gap specifically for cell-based work, though less critical for some biochemical assays. None of these gaps are unique to LY3437943, but because the molecule is larger and more structurally complex than many peptides on the shelf, the value of having all four sections, rather than assuming the missing ones would be fine, is proportionally higher.
Where does Homegrown post the certificate of analysis for a specific LY3437943 lot?
Each LY3437943 vial size Homegrown supplies, and the LY3437943-AM833 blend vial, is tied to a specific lot number, and the current certificate of analysis for that lot is posted alongside the listing on the LY3437943 product page and the LY3437943-AM833 product page. Matching the lot number on the vial in hand to the certificate before running an assay is the same basic check that applies to any research peptide, covered in general terms in the site's broader certificate of analysis guide, but worth repeating here specifically because a mismatch between vial and certificate defeats every other check described above.
Frequently asked questions
Does LY3437943's fatty diacid chain interfere with mass spectrometry identity testing?
No, but it does raise the target mass the test needs to confirm, from a short-peptide range up to the 4731.2 figure reported for the intact, lipidated molecule. A properly calibrated mass spec method accounts for this; the concern is a method validated for smaller peptides being applied without adjustment.
Is net peptide content more important for LY3437943 than for a short peptide?
It is not more or less important in principle, since every lyophilized peptide carries some non-peptide mass. It is worth checking carefully for any larger, more complex molecule because the absolute amount of counter-ion and bound water can differ from what a researcher might assume based on experience with shorter peptides.
What method is standard for endotoxin testing on a research peptide lot?
The limulus amebocyte lysate (LAL) assay is the long-established standard, with recognized variants and known interference considerations depending on the sample matrix (Bolden et al., 2016). Some labs are moving toward alternative pyrogen detection methods, reviewed by Fennrich and colleagues (Fennrich et al., 2016).
Can a lab independently verify a LY3437943 COA's identity claim?
Yes, by sending a sample for independent mass spectrometry testing at a third-party lab, which confirms the observed mass against the published 4731.2 figure rather than relying on the vendor's own certificate alone.
Does a high HPLC purity number guarantee low endotoxin?
No. HPLC purity and endotoxin testing use entirely different methods aimed at different classes of contamination, chemical impurities in one case and bacterial biological contamination in the other. A high purity result says nothing about endotoxin status.
References
- Coskun T, Urva S, Roell WC, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022;34(9):1234-1247.e9. PubMed 35985340.
- Bolden JS, Warburton RE, Phelan R, et al. Endotoxin recovery using limulus amebocyte lysate (LAL) assay. Biologicals. 2016;44(5):434-440. PubMed 27470947.
- Fennrich S, Hennig U, Toliashvili L, et al. More than 70 years of pyrogen detection: Current state and future perspectives. Altern Lab Anim. 2016;44(3):239-253. PubMed 27494624.
- Manning MC, Chou DK, Murphy BM, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PubMed 20143256.
Research use only. Homegrown Peptides products are for laboratory research and are not for human or animal use. Nothing in this article is medical advice.
